Oruka Therapeutics, Inc. (ORKA)
95.81
+5.48
(+6.07%)
USD |
NASDAQ |
Oct 27, 16:00
101.44
+5.63
(+5.88%)
After-Hours: 04:23
Oruka Therapeutics Price to Book Value : 5.264 for Oct. 27, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 27, 2026 | 5.264 |
| October 26, 2026 | 4.962 |
| October 23, 2026 | 4.403 |
| October 22, 2026 | 4.458 |
| October 21, 2026 | 4.391 |
| October 20, 2026 | 4.345 |
| October 19, 2026 | 4.092 |
| October 16, 2026 | 3.952 |
| October 15, 2026 | 4.058 |
| October 14, 2026 | 4.213 |
| October 13, 2026 | 4.296 |
| October 12, 2026 | 4.414 |
| October 09, 2026 | 4.511 |
| October 08, 2026 | 4.246 |
| October 07, 2026 | 4.368 |
| October 06, 2026 | 4.405 |
| October 05, 2026 | 4.636 |
| October 02, 2026 | 4.643 |
| October 01, 2026 | 4.583 |
| September 30, 2026 | 4.576 |
| September 29, 2026 | 4.513 |
| September 28, 2026 | 4.625 |
| September 25, 2026 | 4.640 |
| September 24, 2026 | 4.697 |
| September 23, 2026 | 4.940 |
| Date | Value |
|---|---|
| September 22, 2026 | 5.194 |
| September 21, 2026 | 5.130 |
| September 18, 2026 | 5.217 |
| September 17, 2026 | 5.369 |
| September 16, 2026 | 5.139 |
| September 15, 2026 | 5.065 |
| September 14, 2026 | 5.270 |
| September 11, 2026 | 5.075 |
| September 10, 2026 | 5.035 |
| September 09, 2026 | 5.027 |
| September 08, 2026 | 5.181 |
| September 04, 2026 | 5.082 |
| September 03, 2026 | 4.999 |
| September 02, 2026 | 5.034 |
| September 01, 2026 | 5.060 |
| August 31, 2026 | 5.088 |
| August 28, 2026 | 5.007 |
| August 27, 2026 | 5.304 |
| August 26, 2026 | 5.463 |
| August 25, 2026 | 5.594 |
| August 24, 2026 | 5.627 |
| August 21, 2026 | 5.931 |
| August 20, 2026 | 5.761 |
| August 19, 2026 | 6.026 |
| August 18, 2026 | 6.212 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Tenax Therapeutics, Inc. | 0.4838 |
| Exicure, Inc. | 6.981 |
| Century Therapeutics, Inc. | 1.127 |
| Absci Corp. | 7.368 |
| Celularity, Inc. | -- |
Price to Book Value Related Metrics
| Price | 95.81 |
| Earnings Yield | -2.57% |
| Market Cap | 5.851B |